Naoki Terada

3.7k total citations
145 papers, 2.6k citations indexed

About

Naoki Terada is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Naoki Terada has authored 145 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 35 papers in Surgery and 33 papers in Molecular Biology. Recurrent topics in Naoki Terada's work include Prostate Cancer Treatment and Research (47 papers), Prostate Cancer Diagnosis and Treatment (34 papers) and Urinary Bladder and Prostate Research (20 papers). Naoki Terada is often cited by papers focused on Prostate Cancer Treatment and Research (47 papers), Prostate Cancer Diagnosis and Treatment (34 papers) and Urinary Bladder and Prostate Research (20 papers). Naoki Terada collaborates with scholars based in Japan, United States and China. Naoki Terada's co-authors include Yoichi Arai, Koji Yoshimura, Kentaro Ichioka, Akito Terai, Osamu Ogawa, Yosuke Matsuta, Kazutoshi Okubo, Takahiro Inoue, Takashi Kobayashi and Yoshiyuki Matsui and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Naoki Terada

138 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoki Terada Japan	29	1.2k	878	607	491	391	145	2.6k
Luc Baert Belgium	30	1.7k 1.5×	848 1.0×	345 0.6×	687 1.4×	606 1.5×	101	2.8k
Tetsuya Fujimura Japan	35	1.2k 1.1×	1.4k 1.6×	632 1.0×	729 1.5×	766 2.0×	205	3.8k
Yoshiyuki Matsui Japan	27	733 0.6×	679 0.8×	630 1.0×	1.0k 2.1×	241 0.6×	178	2.6k
Hidefumi Kinoshita Japan	25	1.3k 1.1×	914 1.0×	215 0.4×	663 1.4×	403 1.0×	222	2.8k
Kouji Izumi Japan	29	1.4k 1.3×	888 1.0×	349 0.6×	430 0.9×	454 1.2×	219	3.4k
Toshiyuki Kamoto Japan	37	1.6k 1.4×	1.4k 1.6×	386 0.6×	788 1.6×	602 1.5×	262	3.9k
Steven A. Bigler United States	31	1.5k 1.3×	825 0.9×	167 0.3×	562 1.1×	382 1.0×	79	3.3k
Nobumichi Tanaka Japan	29	1.3k 1.1×	656 0.7×	434 0.7×	899 1.8×	314 0.8×	248	3.0k
Takashi Ohigashi Japan	25	926 0.8×	547 0.6×	159 0.3×	395 0.8×	372 1.0×	94	2.1k
Constantinos Constantinides Greece	24	623 0.5×	422 0.5×	408 0.7×	581 1.2×	165 0.4×	105	1.7k

Countries citing papers authored by Naoki Terada

Since Specialization

Citations

This map shows the geographic impact of Naoki Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Terada more than expected).

Fields of papers citing papers by Naoki Terada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Terada. The network helps show where Naoki Terada may publish in the future.

Co-authorship network of co-authors of Naoki Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Terada. A scholar is included among the top collaborators of Naoki Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Terada. Naoki Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishimura, Nobutaka, Makito Miyake, Kota Iida, et al.. (2024). Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis. World Journal of Urology. 42(1). 185–185. 2 indexed citations

Kobayashi, Takahiko, et al.. (2023). Use of the anterior prostatic urethral mucosa preservation technique during holmium laser enucleation of the prostate can reduce postoperative stress urinary incontinence. Asian Journal of Endoscopic Surgery. 17(1). e13256–e13256. 2 indexed citations

Tohi, Yoichiro, Ryou Ishikawa, Takuma Kato, et al.. (2023). Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort. Japanese Journal of Clinical Oncology. 53(10). 984–990. 1 indexed citations

Terada, Naoki, Keiji Nihei, Masaki Shiota, et al.. (2022). Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer. Japanese Journal of Clinical Oncology. 52(6). 633–641. 1 indexed citations

Fukuokaya, Wataru, Takahiro Kimura, Kazumasa Komura, et al.. (2022). Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors. Urologic Oncology Seminars and Original Investigations. 40(7). 346.e1–346.e8. 18 indexed citations

Narita, Shintaro, Naoki Terada, Kyoko Nomura, et al.. (2022). Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy. International Journal of Urology. 29(10). 1147–1154.

Terada, Naoki, Masato Fujii, Shoichiro Mukai, et al.. (2022). Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models. Cancer Reports. 6(2). e1701–e1701. 2 indexed citations

Nagumo, Yoshiyuki, Mizuki Onozawa, Takahiro Kojima, et al.. (2022). Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden. International Journal of Urology. 29(5). 398–405. 7 indexed citations

Nishimura, Nobutaka, Makito Miyake, Kota Iida, et al.. (2021). Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy. International Journal of Urology. 29(3). 242–249. 1 indexed citations

10.

Ichioka, Kentaro, Yoshiyuki Matsui, Naoki Terada, et al.. (2020). Three‐dimensional simulation analysis of microdissection testicular sperm extraction for patients with non‐obstructive azoospermia. Andrology. 8(5). 1214–1221. 6 indexed citations

11.

Kobayashi, Takashi, Naoki Terada, Takahiro Kimura, et al.. (2019). Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up. Clinical Genitourinary Cancer. 18(1). e46–e54. 9 indexed citations

12.

Yamasaki, Koji, Masato Fujii, Naoki Terada, et al.. (2019). <p>Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis</p>. Research and Reports in Urology. Volume 11. 97–104. 5 indexed citations

13.

Goto, Takayuki, Takahiro Inoue, Takashi Kobayashi, et al.. (2019). Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations. International Journal of Clinical Oncology. 25(1). 126–134. 6 indexed citations

14.

Yamasaki, Koji, et al.. (2018). Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer. Research and Reports in Urology. Volume 10. 135–144. 19 indexed citations

15.

Funada, Satoshi, Takahisa Kawaguchi, Naoki Terada, et al.. (2016). Population-Based Survey of Overactive Bladder in Japan: A Cross-Sectional Analysis of the Nagahama study. Neurourology and Urodynamics. 1 indexed citations

16.

Zeng, Yu, Dong Gao, Takumi Shiraishi, et al.. (2013). Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing. Cancer Research. 73(13). 4123–4133. 49 indexed citations

17.

Zeng, Yu, Dong Gao, John J. Kim, et al.. (2013). Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production.. PubMed Central. 1(1). 39–52. 20 indexed citations

18.

Terada, Naoki, Prakash Kulkarni, & Robert H. Getzenberg. (2012). Cyr61 is a potential prognostic marker for prostate cancer. Asian Journal of Andrology. 14(3). 405–408. 22 indexed citations

19.

Shimizu, Yosuke, Yoko Hamazaki, Masakazu Hattori, et al.. (2011). SPA‐1 controls the invasion and metastasis of human prostate cancer. Cancer Science. 102(4). 828–836. 34 indexed citations

20.

Segawa, Takehiko, Takahiro Inoue, Taizo Shiraishi, et al.. (2007). Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men. British Journal of Urology. 100(3). 685–690. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact